EPIC
invIOs GmbH
Mark For: EPIC™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97642362 |
| Mark Literal Elements | EPIC |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark, Service Mark |
| Current Location | NEW APPLICATION PROCESSING 2022-10-25 |
| Basis | 1(b) 44(d) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael J. Leonard |
| Attorney Docket Number | 191159.00022 |
Timeline
| 2022-10-21 | Application Filed |
| 2022-10-25 | Location: NEW APPLICATION PROCESSING |
| 2022-10-25 | Status: Live/Pending |
| 2022-10-25 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
| 2022-10-25 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  invIOs GmbH |
| Address | Campus-Vienna-Biocenter 5 Wien AUSTRIA 1030 |
| Legal Entity Type | Gesellschaft Mit Beschränkter Haftung (gmbh) |
| Legal Entity State | AUSTRIA |
Documents
 Application | 2022-10-21 | |
| Drawing | 2022-10-21 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Human immune cells, in particular T cells, for medical or clinical purposes; human immune cells, in particular T cells, for scientific and medical research; biological and pharmaceutical compositions containing human immune cells, in particular T cells; biological and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; Biological and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2022-10-25 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 